Answers are grounded in this paper and cite their sources.
Highlights a rare case of vaccine-associated paralytic poliomyelitis in an immunocompetent individual following OPV administration.
To the Editor: Poliomyelitis was a major health problem in the United States until the introduction of inactivated poliovirus vaccine and attenuated oral poliovirus vaccine (OPV) in 1955 and 1961, respectively. Since 1963, trivalent OPV has been used routinely. Cases of vaccine-associated paralytic poliomyelitis have been described in recipients of this vaccine and contacts who were either immunodeficient or inadequately vaccinated1–4. We report a case of vaccine-associated paralytic poliomyelitis (the only 1 of 284 such cases reported to the Centers for Disease Control and Prevention [CDC] from 1961 through 1991) in an immunocompetent man who had received a . . .
No takes yet. Share an insight, caveat, or question.
Mermel et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: